Celgene News

Latest Celgene News

Disclaimer: IPD Group, the publisher of EIN News, is an independent news monitoring company. There is no affiliation between IPD Group and Celgene. EIN News Report: Celgene is a media monitoring website that has not been generated, sponsored or otherwise approved by Celgene.

NEJM publishes results from Celgene’s REVLIMID phase III studies on MM
11 May 07:43 GMT

Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG), today announced … , multicenter, randomized study conducted by Celgene compared melphalan-prednisone-lenalidomide induction followed by …
Celgene hires Thomas Moriarty to lead legal strategy
9 May 06:52 GMT

Thomas Moriarty has joined Celgene as general counsel and corporate … Hugin, chair and CEO of Celgene. “His extensive legal background, as …
Celgene Sets The Stage For Patient Investors
8 May 22:31 GMT

… up stock, Celgene (CELG), also may reward patient shareholders. Celgene shares have … it launches in new markets. Celgene expects additional multiple myeloma approvals … of market moving news. But Celgene's success isn… Q1 to $104 million. And Celgene thinks the market for Abraxane …
Celgene Corporation To Present At Baird Stock Conference ; Webcast At 12:20 PM
8 May 17:11 GMT

… :20 AM ET (RTTNews) - Celgene Corporation (CELG: News ) will present … webcast, log on at www.celgene.com Click here to receive … breaking news email alerts for Celgene Corporation and others in your …
FDA: Celgene Drug Revlimid Increases Risk Of Certain New Cancers
7 May 21:07 GMT

… said certain patients treated with Celgene Corp.'s (CELG) cancer …
Celgene Corporation Announces Appointment of Thomas M. Moriarty as General Counsel
7 May 11:36 GMT

… Management Committee. Mr. Moriarty joins Celgene from Medco Health Solutions where … law from Lafayette College. About Celgene Celgene Corporation, headquartered in Summit, New … . For Celgene: Investors: 908-673-9628 investors@celgene.com or Media: 908-673-2275 media@celgene.com …
International Myeloma Foundation: Celgene Submits Pomalidomide for FDA Approval [Professional Services Close - Up]
6 May 10:04 GMT

International Myeloma Foundation: Celgene Submits Pomalidomide for FDA Approval [ … drug, called pomalidomide, developed by Celgene, would be used for patients …
International Myeloma Foundation: Celgene Submits Pomalidomide for FDA Approval [Health & Beauty Close - Up]
2 May 13:36 GMT

International Myeloma Foundation: Celgene Submits Pomalidomide for FDA Approval [ … drug, called pomalidomide, developed by Celgene, would be used for patients …
Critical Alerts For MasterCard, Celgene, Tempur-Pedic, AstraZeneca, and Sotheby's Released By Invest
30 Apr 16:02 GMT

… following stocks: MasterCard (NYSE: MA), Celgene (Nasdaq: CELG), Tempur-Pedic (NYSE: TPX …
Deal Announced Today Between Celgene Corporation and Epizyme, an LLS-partner, Will Help Advance a Th
29 Apr 19:59 GMT

… . Epizyme's partnership with Celgene, announced today, will be a … Louis DeGennaro, Ph.D. "Celgene brings a track record of … action." Earlier this year, Celgene Corporation acquired another LLS-partner, Avila …
Celgene Reports Q1 Results: Seeing Further Upside
29 Apr 16:03 GMT

… little effect fundamentally moving forward. Celgene's latest earnings release …
Summit-based Celgene slips as first quarter results fall short of views
26 Apr 23:18 GMT

… short of Wall Street estimates. Celgene, which is based in Summit … the production of blood cells. Celgene said revenue from its breast … a potential treatment for leukemia. Celgene agreed to pay Epizyme $90 … milestone payments for each drug Celgene chooses to develop, along with …
Celgene slips as 1Q results fall short of views
26 Apr 18:30 GMT

… short of Wall Street estimates. Celgene said its profit rose to … the production of blood cells. Celgene said revenue from its breast … a potential treatment for leukemia. Celgene agreed to pay Epizyme $90 … milestone payments for each drug Celgene chooses to develop, along with …
Aetna, Celgene Corporation Among Stocks Down on High Volume Thursday
26 Apr 18:14 GMT

… .4% above the mark. Today, Celgene Corporation (CELG) is down on …
Epizyme Forms Strategic Partnership with Industry Leader in Epigenetic Therapies, Celgene Corporation, to Develop ...
26 Apr 17:49 GMT

… . www.epizyme.com About Celgene International Sàrl Celgene International Sàrl, located in … subsidiary and international headquarters of Celgene Corporation. Celgene Corporation, headquartered in Summit … 's website at www.celgene.com. Celgene Forward-Looking Statements This press …
Celgene Stock Drops As Q1 Earnings Miss Expectations
26 Apr 16:06 GMT

… :05 AM ET Leading biotech Celgene (CELG) got stopped in its … well into the future." Celgene guided 2012 revenue of $5 … side of estimates but affirming Celgene's previous guidance. The …
Epizyme joins Celgene in $90M-plus partnership
26 Apr 15:49 GMT

… formed a strategic partnership with Celgene International Sarl of New Jersey … by Celgene. And for each histone methyltransferase (HMT) inhibitor that Celgene licenses … outside the United States. Celgene International, a Celgene Corp. subsidiary, and Epizyme …
Celgene Q1 Results Miss Estimates; But Reaffirms 2012 Outlook
26 Apr 15:30 GMT

… (RTTNews) - Integrated biopharmaceutical company Celgene Corp. (CELG: News ) reported Thursday … breaking news email alerts for Celgene Corporation and others in your …
Celgene Pays Epizyme $90M for Ex-U.S. Rights to Histone Methyltransferase Inhibitor
26 Apr 13:45 GMT

… each HMT inhibitor licensed by Celgene, and potentially double-digit royalties on … global development of collaborative programs. Celgene’s expertise in epigenetic cancer … collaboration, Epizyme gains access to Celgene’s leading drug development resources …
Celgene Corporation Q1 12 Earnings Conference Call At 9:00 AM ET
26 Apr 13:16 GMT

… :59 AM ET (RTTNews) - Celgene Corporation. (CELG: News ) will host … webcast, log on at www.celgene.com Click here to receive … breaking news email alerts for Celgene Corporation and others in your …
Celgene Reports First Quarter 2012 Operating and Financial Results
26 Apr 13:12 GMT

Celgene CorporationPosted on:26 Apr 12 Celgene Corporation (NASDAQ: CELG) reported Non-GAAP … anthracycline unless clinically contraindicated. About Celgene Celgene Corporation, headquartered in Summit, New … law and acquisition related matters. Celgene Corporation and Subsidiaries Reconciliation of …

1 2 3 4 5 6 7 8 9 10 11 Next

EIN NEWS REPORT: CELGENE			BACK TO TOP

Account Info:

My Account
Subscriber Billing Info
Member Center
- Change your billing and/or user information
- Extend your subscription period
- Re-activate an expired account
- Manage your Email Alerts
- Add additional users to your account
- Manage your additional user account(s)
- Retrieve a lost password
- Get an invoice for your subscription
- Cancel your account by sending us an email through the feedback form

Create an Account:

Help & Information Center:

Submit

About

Navigate:

Tools and Formats:

EIN News Home
About EIN News

Founded in 1995, EIN News is an international leader in real-time news tracking and digital information services. Our systems continuously scan the web, indexing news from thousands of worldwide sources. The data is then filtered and organized into news streams. The process is supervised by a team of professional news editors.

We are news professionals and technologists dedicated to producing the fastest and most comprehensive news streams on the planet. We are committed to providing our members with the highest quality software tools and resources available.

EIN News is a division of Internet Product Development Group Inc.
To reach us send an email or call +1 202 657 5158.
EIN Presswire
EIN Marketplace
EIN Events and Conferences
Newsfeed Maker
Inbox Robot
IPD Group
EIN Twitter
EIN Facebook

+ EIN News Report: Celgene = Unlimited access to real-time news

Create your EIN News account now.

ALL NEWS PUBLICATIONS

EIN News provides breaking news coverage on the following topics: